Genetic polymorphisms in CYP2E1: association with schizophrenia susceptibility and risperidone response in the Chinese Han population.
CYP2E1 is a member of the cytochrome P450 superfamily, which is involved in the metabolism and activation of both endobiotics and xenobiotics. The genetic polymorphisms of CYP2E1 gene (Chromosome 10q26.3, Accession Number NC_000010.10) are reported to be related to the development of several mental...
Main Authors: | Ran Huo, Kefu Tang, Zhiyun Wei, Lu Shen, Yuyu Xiong, Xi Wu, Jiamin Niu, Xia Han, Zhengan Tian, Lun Yang, Guoyin Feng, Lin He, Shengying Qin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3350493?pdf=render |
Similar Items
-
The PstI/RsaI and DraI polymorphisms of <it>CYP2E1 </it>and head and neck cancer risk: a meta-analysis based on 21 case-control studies
by: Xiong Yuyu, et al.
Published: (2010-10-01) -
CYP2D6 polymorphisms and their influence on risperidone treatment
by: Puangpetch A, et al.
Published: (2016-12-01) -
Association of CYP2D6 polymorphisms and extrapyramidal symptoms in schizophrenia patients receiving risperidone: a retrospective study
by: Takahiro Ito, et al.
Published: (2018-11-01) -
Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone
by: Jinjun Lu, et al.
Published: (2021-02-01) -
A prospective study to evaluate the effect of CYP2D6 polymorphism on plasma level of risperidone and its metabolite in North Indian patients with schizophrenia
by: Bir S Chavan, et al.
Published: (2018-01-01)